https://www.medscape.com/viewarticle/cancer-biosimilars-falling-prices-rising-margins-2026a100092n
In the US, hospital acquisition prices for oncology biosimilars have dropped faster than reimbursement prices from insurers, leading to an increase in hospital margins, new findings showed.
No hay comentarios:
Publicar un comentario